💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Opioid Addiction Growth Fueled by Cryptos; Could Affect Regulatory Actions In the Space

Published 04/14/2018, 03:56 AM
Updated 04/14/2018, 10:31 AM
 Opioid Addiction Growth Fueled by Cryptos; Could Affect Regulatory Actions In the Space
BTC/USD
-

Two years ago, seven packages of fentanyl were seized at a New York airport. This year the number of packages seized so far is 146, and most of it was bought and paid for with cryptocurrencies.

This is exactly what will likely prompt U.S. lawmakers to step up the process in putting regulations in place for the crypto space.

In several recent hearings, lawmakers have voiced their concerns about cryptos being used to purchase opioids, which is fueling the country’s soaring addiction problem.

The crypto/opioid connection was highlighted in a recent CNBC report.

Let’s discuss.

Where there is a will there’s a way

Criminals have long used the DarkWeb to sell and buy anything that could be illegal. Mostly credit and debit cards had been used.

Now authorities are seeing an uptick in the use of cryptos, especially Bitcoin.

The perceived anonymity of cryptos make criminals and users see them as the perfect means for criminals to purchase illicit drugs. What’s loss upon many people, however, is that their transactions are not completely anonymous. Users have to convert their money through an exchange, which collects their personal information.

No matter, cryptos are still increasingly being used to make these illegal purchases.

It appears that the drug fentanyl is one of the top drugs being sought.

Sellers recognize this, and have become so brazen in attracting buyers that they often offer discounts for people buying with Bitcoin.

According to CNBC, dealers have advertised that they’d switched to Bitcoin payments only, and offer a 10% discount. Noted also was that by paying with the crypto, the buyer could make unlimited purchases.

Congressional concerns

During hearings earlier this year, Congressional leaders were schooled about cryptocurrencies by the chairs of the U.S. Securities and Exchange Commission and the U.S. Commodity Futures Trading Commission. They were also hearings in which several industry experts spoke to them.

One of the main questions that continued to be asked of these experts by Congressional members related to controlling the use of cryptos from being used to make drug purchases.

Bills have been introduced that directly relate to digital currencies, but so far none has been passed out of either the House of Representatives or the Senate.


This article appeared first on Cryptovest

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.